Clinical trial
Randomized Evaluation of a Low-Frequency Investigational Device Employing Neuromodulation Therapy in Patients With Fibromyalgia
NCT00450905 is registered in ClinicalTrials.gov with Fralex Therapeutics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Evaluation of a Low-Frequency Investigational Device Employing Neuromodulation Therapy in Patients With Fibromyalgia
- Lead sponsor
- Fralex Therapeutics
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- March 31, 2007
- Completion date
- December 31, 2008
- Enrollment
- 200 (estimated)
- Sites
- 21
Conditions
As the registry lists them; a condition with its own page is linked.